====================
QUESTION:
{
  "CASE_CORE": {
    "VISIT_DATE": "2024-07-17",
    "last_platinum_end_date": "Unknown",
    "first_relapse_date": "Unknown",
    "PFI_days": "Unknown",
    "PLATINUM_STATUS": "Unknown",
    "PLATINUM_STATUS_CURRENT": "Unknown",
    "PLATINUM_PFI_CURRENT": "Unknown",
    "SCENE": "Frontline_PDS_or_NACT_IDS",
    "PLATINUM_HISTORY": [],
    "DIAGNOSIS": {
      "primary": "卵巢恶性肿瘤",
      "histology": "高级别浆液性癌",
      "site": "Pelvis/ovary",
      "laterality": "Bilateral",
      "components": [
        "ovary",
        "fallopian tube",
        "pelvic peritoneum",
        "omentum",
        "right paracolic gutter tumor"
      ]
    },
    "STAGE": {
      "stage_text": "Unknown",
      "stage_system": "Unknown",
      "stage_basis": "Unknown"
    },
    "INITIAL_TREATMENT": "Yes",
    "SURGERY_DONE": {
      "performed": "Yes",
      "date": "2024-06-06",
      "procedure": "Pelvic mass resection; bilateral salpingo-oophorectomy; pelvic peritoneum resection; omentectomy; appendectomy; tumor debulking; complex adhesiolysis"
    },
    "NEOADJUVANT": "Unknown",
    "ADJUVANT_TREATMENT": {
      "given": "Unknown",
      "regimens": [],
      "cycles_or_courses": "Unknown"
    },
    "LINE_OF_THERAPY": [],
    "MAINTENANCE": "Unknown",
    "MAINTENANCE_DETAIL": {
      "given": "Unknown",
      "regimens": [],
      "start_date": "Unknown",
      "end_date": "Unknown"
    },
    "RELAPSE": "No",
    "RELAPSE_DATE": {
      "date": "Unknown",
      "type": "Unknown",
      "evidence": ""
    },
    "HRD": "Unknown",
    "BRCA1": "Unknown",
    "BRCA2": "Unknown",
    "BIOMARKERS": {
      "TMB": "Unknown",
      "MSI": "Unknown",
      "PDL1_CPS": "Unknown",
      "HER2": "0",
      "AFP": "Unknown",
      "CA125": "Unknown"
    },
    "CURRENT_STATUS": "Postoperative; ureter not removed at postoperative follow-up",
    "TIMELINE": {
      "events": [
        {
          "date": "2024-06-05",
          "event_type": "Imaging",
          "description": "Ultrasound: right breast outer-lower solid nodule with calcification (BI-RADS 4B); left breast solid nodule BI-RADS 3; bilateral axilla no obvious mass; lower limb veins no abnormality",
          "regimen_or_test": "Ultrasound",
          "key_result": "Right breast nodule BI-RADS 4B"
        },
        {
          "date": "Unknown",
          "event_type": "Imaging",
          "description": "FDG-PET/CT: pelvic cystic-solid mass with FDG-avid solid component; possible malignancy and peritoneal metastasis; small pelvic effusion; FDG-avid right breast outer-lower density, recommend biopsy; other findings",
          "regimen_or_test": "FDG-PET/CT",
          "key_result": "Pelvic mass FDG-avid; right breast FDG-avid"
        },
        {
          "date": "2024-06-06",
          "event_type": "Surgery",
          "description": "Pelvic mass resection + bilateral adnexectomy + pelvic peritoneum resection + omentectomy + appendectomy + debulking + complex adhesiolysis",
          "regimen_or_test": "Surgery",
          "key_result": "Operative resection of pelvic mass and multiple specimens obtained"
        },
        {
          "date": "2024-06-06",
          "event_type": "Pathology",
          "description": "Pelvic mass pathology initial: low-differentiation carcinoma, tending to high-grade serous carcinoma, size 5*3*2 cm; awaiting IHC",
          "regimen_or_test": "Histopathology",
          "key_result": "Low-differentiation carcinoma, favor high-grade serous"
        },
        {
          "date": "2024-06-17",
          "event_type": "Pathology",
          "description": "Supplementary pathology: high-grade serous carcinoma of pelvic mass, size 5*3*2 cm; immunohistochemistry provided",
          "regimen_or_test": "Supplementary pathology and IHC",
          "key_result": "Diagnosis: 高级别浆液性癌; IHC results documented"
        },
        {
          "date": "Unknown",
          "event_type": "Pathology",
          "description": "Right breast core biopsy: invasive carcinoma with ductal carcinoma in situ component",
          "regimen_or_test": "Core needle biopsy",
          "key_result": "Right breast invasive carcinoma with DCIS"
        },
        {
          "date": "Unknown",
          "event_type": "Pathology",
          "description": "Right breast simple mastectomy specimen: invasive carcinoma, NST, with DCIS, tumor 2*2*1.5 cm, pT1cN0Mx; IHC results documented",
          "regimen_or_test": "Mastectomy pathology",
          "key_result": "pT1cN0Mx; ER/PR positive; HER2 1+"
        }
      ],
      "constraints": {
        "min_events": 3,
        "max_events": 30,
        "must_include": [
          "first diagnostic imaging or pathology confirmation (if available)"
        ],
        "ordering_rules": {
          "prioritize_last_event": true
        }
      }
    }
  },
  "TIMELINE": {
    "events": [
      {
        "date": "2024-06-05",
        "event_type": "Imaging",
        "description": "Ultrasound: right breast outer-lower solid nodule with calcification (BI-RADS 4B); left breast solid nodule BI-RADS 3; bilateral axilla no obvious mass; lower limb veins no abnormality",
        "regimen_or_test": "Ultrasound",
        "key_result": "Right breast nodule BI-RADS 4B"
      },
      {
        "date": "Unknown",
        "event_type": "Imaging",
        "description": "FDG-PET/CT: pelvic cystic-solid mass with FDG-avid solid component; possible malignancy and peritoneal metastasis; small pelvic effusion; FDG-avid right breast outer-lower density, recommend biopsy; other findings",
        "regimen_or_test": "FDG-PET/CT",
        "key_result": "Pelvic mass FDG-avid; right breast FDG-avid"
      },
      {
        "date": "2024-06-06",
        "event_type": "Surgery",
        "description": "Pelvic mass resection + bilateral adnexectomy + pelvic peritoneum resection + omentectomy + appendectomy + debulking + complex adhesiolysis",
        "regimen_or_test": "Surgery",
        "key_result": "Operative resection of pelvic mass and multiple specimens obtained"
      },
      {
        "date": "2024-06-06",
        "event_type": "Pathology",
        "description": "Pelvic mass pathology initial: low-differentiation carcinoma, tending to high-grade serous carcinoma, size 5*3*2 cm; awaiting IHC",
        "regimen_or_test": "Histopathology",
        "key_result": "Low-differentiation carcinoma, favor high-grade serous"
      },
      {
        "date": "2024-06-17",
        "event_type": "Pathology",
        "description": "Supplementary pathology: high-grade serous carcinoma of pelvic mass, size 5*3*2 cm; immunohistochemistry provided",
        "regimen_or_test": "Supplementary pathology and IHC",
        "key_result": "Diagnosis: 高级别浆液性癌; IHC results documented"
      },
      {
        "date": "Unknown",
        "event_type": "Pathology",
        "description": "Right breast core biopsy: invasive carcinoma with ductal carcinoma in situ component",
        "regimen_or_test": "Core needle biopsy",
        "key_result": "Right breast invasive carcinoma with DCIS"
      },
      {
        "date": "Unknown",
        "event_type": "Pathology",
        "description": "Right breast simple mastectomy specimen: invasive carcinoma, NST, with DCIS, tumor 2*2*1.5 cm, pT1cN0Mx; IHC results documented",
        "regimen_or_test": "Mastectomy pathology",
        "key_result": "pT1cN0Mx; ER/PR positive; HER2 1+"
      }
    ],
    "constraints": {
      "min_events": 3,
      "max_events": 30,
      "must_include": [
        "first diagnostic imaging or pathology confirmation (if available)"
      ],
      "ordering_rules": {
        "prioritize_last_event": true
      }
    }
  },
  "MED_ONC": {
    "current_regimen": {
      "name": "Unknown",
      "last_admin_date": "Unknown",
      "cycle_info": "Unknown"
    },
    "planned_next_regimen": "Unknown",
    "prior_systemic_therapies": [],
    "genetic_testing": {
      "somatic": [],
      "germline": []
    },
    "monitoring_points": []
  },
  "RADIOLOGY": {
    "studies": [
      {
        "date": "2024-06-05",
        "modality": "US",
        "anatomic_sites": [
          "breasts"
        ],
        "findings": [
          "Right outer-lower breast solid nodule with calcification (BI-RADS 4B)",
          "Bilateral lobular hyperplasia",
          "Left breast solid nodule (BI-RADS 3)",
          "No obvious axillary masses bilaterally",
          "Lower limb veins unremarkable"
        ],
        "impression": "Right breast outer-lower solid nodule with calcification (BI-RADS 4B); left breast nodule BI-RADS 3",
        "trend_vs_prior": "Unknown"
      },
      {
        "date": "Unknown",
        "modality": "Other",
        "anatomic_sites": [
          "pelvis",
          "breasts",
          "neck lymph nodes",
          "lungs",
          "gallbladder"
        ],
        "findings": [
          "Pelvic cystic-solid mass closely related to uterus and adnexa; solid component FDG-avid",
          "Possible malignant tumor in pelvis; peritoneal metastasis; small pelvic effusion",
          "Right breast outer-lower dense shadow FDG-avid, recommend biopsy",
          "Bilateral neck lymph nodes inflammatory hyperplasia",
          "Right lower lung nodule without FDG uptake (follow-up)",
          "Left upper lung chronic focus",
          "Possible cholecystitis"
        ],
        "impression": "FDG-avid pelvic mass suggesting malignancy with peritoneal involvement; FDG-avid right breast lesion, biopsy recommended",
        "trend_vs_prior": "Unknown"
      }
    ],
    "next_imaging_plan": {
      "modality": "Unknown",
      "timing": "Unknown"
    }
  },
  "PATHOLOGY": {
    "specimens": [
      {
        "date": "2024-06-06",
        "site": "Pelvic mass",
        "diagnosis": "低分化癌，倾向高级别浆液性癌",
        "components": [
          "pelvic mass"
        ],
        "grade": "Low differentiated",
        "tumor_size": "5*3*2cm",
        "laterality": "Unknown",
        "sample_type": "Resection",
        "involvement_sites": [
          "bilateral ovaries",
          "fallopian tubes",
          "pelvic peritoneum",
          "omentum"
        ],
        "ihc": [
          {
            "marker": "ER",
            "result": "部分+"
          },
          {
            "marker": "PR",
            "result": "-"
          },
          {
            "marker": "P53",
            "result": "-，突变型"
          },
          {
            "marker": "WT1",
            "result": "+"
          },
          {
            "marker": "Ki-67",
            "result": "+60%"
          },
          {
            "marker": "HER2",
            "result": "0"
          },
          {
            "marker": "HNF1B",
            "result": "-"
          },
          {
            "marker": "NapsinA",
            "result": "-"
          },
          {
            "marker": "P16",
            "result": "部分+"
          },
          {
            "marker": "IMP3",
            "result": "+"
          },
          {
            "marker": "PAX8",
            "result": "+"
          }
        ],
        "molecular": [],
        "raw_text": "2024.06.06行盆腔肿块切除术...（盆腔肿块）低分化癌，倾向高级别浆液性癌，大小5*3*2cm，请待免疫组化辅助诊断。",
        "uncertainty_or_missing": [
          "Initial report: awaiting IHC"
        ]
      },
      {
        "date": "2024-06-17",
        "site": "Pelvic mass (supplement)",
        "diagnosis": "高级别浆液性癌",
        "components": [
          "pelvic mass"
        ],
        "grade": "Unknown",
        "tumor_size": "5*3*2cm",
        "laterality": "Unknown",
        "sample_type": "Supplementary pathology with IHC",
        "involvement_sites": [
          "bilateral ovaries",
          "fallopian tubes",
          "pelvic peritoneum",
          "omentum"
        ],
        "ihc": [
          {
            "marker": "ER",
            "result": "部分+"
          },
          {
            "marker": "PR",
            "result": "-"
          },
          {
            "marker": "P53",
            "result": "-，突变型"
          },
          {
            "marker": "WT1",
            "result": "+"
          },
          {
            "marker": "Ki-67",
            "result": "+60%"
          },
          {
            "marker": "HER2",
            "result": "0"
          },
          {
            "marker": "HNF1B",
            "result": "-"
          },
          {
            "marker": "NapsinA",
            "result": "-"
          },
          {
            "marker": "P16",
            "result": "部分+"
          },
          {
            "marker": "IMP3",
            "result": "+"
          },
          {
            "marker": "PAX8",
            "result": "+"
          }
        ],
        "molecular": [],
        "raw_text": "补充报告日期：2024-06-17；（盆腔肿块）高级别浆液性癌，大小5*3*2cm。【补充免疫组化结果】瘤细胞示：ER（部分+），PR（-），P53（-，突变型），WT1（+），Ki-67（+60%），HER2（0），HNF1B（-），NapsinA（-），P16（部分+），IMP3（+），PAX8（+）。",
        "uncertainty_or_missing": []
      },
      {
        "date": "Unknown",
        "site": "Large pelvic mass / omental mass",
        "diagnosis": "低分化癌",
        "components": [
          "巨大盆块",
          "omentum"
        ],
        "grade": "Low differentiated",
        "tumor_size": "10×6×5.5cm",
        "laterality": "Unknown",
        "sample_type": "Resection",
        "involvement_sites": [
          "bilateral ovaries",
          "fallopian tubes",
          "pelvic peritoneum",
          "omentum",
          "right paracolic gutter tumor"
        ],
        "ihc": [],
        "molecular": [],
        "raw_text": "（巨大盆块+双附件+全盆底腹膜+大网膜肿块）低分化癌，大小10×6×5.5cm。双侧卵巢及输卵管及盆底腹膜及大网膜均见癌累及。（大网膜）见癌累及。（右结肠旁沟肿瘤）见癌累及。（阑尾）慢性炎。",
        "uncertainty_or_missing": []
      },
      {
        "date": "Unknown",
        "site": "Right breast core biopsy",
        "diagnosis": "浸润性癌，伴部分导管原位癌",
        "components": [
          "breast core biopsy"
        ],
        "grade": "Unknown",
        "tumor_size": "Unknown",
        "laterality": "Right",
        "sample_type": "Core needle biopsy",
        "involvement_sites": [],
        "ihc": [],
        "molecular": [],
        "raw_text": "右乳空心针穿刺;（右乳）浸润性癌，伴部分导管原位癌。",
        "uncertainty_or_missing": []
      },
      {
        "date": "Unknown",
        "site": "Right breast mastectomy",
        "diagnosis": "Invasive carcinoma, non-special type, with DCIS component",
        "components": [
          "breast"
        ],
        "grade": "Ⅱ级",
        "tumor_size": "2*2*1.5 cm",
        "laterality": "Right",
        "sample_type": "Mastectomy",
        "involvement_sites": [
          "axillary lymph nodes (0/3)"
        ],
        "ihc": [
          {
            "marker": "ER",
            "result": "+>80％，强"
          },
          {
            "marker": "PR",
            "result": "+>80％，中-强"
          },
          {
            "marker": "HER2",
            "result": "1+"
          },
          {
            "marker": "Ki-67",
            "result": "+<10％"
          },
          {
            "marker": "AR",
            "result": "+>80％，强"
          },
          {
            "marker": "CD8",
            "result": "+<10％"
          },
          {
            "marker": "FOXC1",
            "result": "-"
          },
          {
            "marker": "E-Cad",
            "result": "+"
          },
          {
            "marker": "P120",
            "result": "膜+"
          },
          {
            "marker": "CK5/6",
            "result": "-"
          },
          {
            "marker": "P63",
            "result": "-"
          },
          {
            "marker": "GATA3",
            "result": "+"
          },
          {
            "marker": "TRPS1",
            "result": "+"
          },
          {
            "marker": "GCDFP15",
            "result": "-"
          }
        ],
        "molecular": [],
        "raw_text": "右乳腺单纯切除术...组织学类型:浸润性癌，非特殊类型，伴导管原位成分。组织学分级:Ⅱ级...腋窝淋巴结(0/3)...PTNM分期:pT1cN0Mx。瘤细胞示：ER（+>80％，强），PR（+>80％，中-强），HER2（1+），Ki-67（+<10％），AR（+>80％，强）等。",
        "uncertainty_or_missing": []
      }
    ]
  },
  "NUC_MED": {
    "studies": []
  },
  "LAB_TRENDS": {
    "labs": [],
    "milestones": [
      {
        "date": "2024-06-06",
        "type": "Surgery",
        "description": "Pelvic mass resection and multiple procedures",
        "title": "Surgery"
      }
    ]
  }
}

RESPONSE:
Final Assessment:
Postoperative bilateral tubo‑ovarian high‑grade serous carcinoma with peritoneal involvement and synchronous early-stage ER+/HER2‑ breast cancer; staging, BRCA/HRD status, labs, and imaging remain incomplete.

Core Treatment Strategy:
- Prioritize completion of integrated gyn-onc pathology report and formal FIGO staging, including documentation of residual disease and margins.
- Obtain baseline CBC, renal/hepatic function, performance status, and venous access assessment before starting any systemic therapy.
- Arrange dedicated postoperative pelvic CT/MRI, serial chest CT, and full PET/CT report review to define residual disease and lung nodule significance.
- Initiate standard adjuvant systemic therapy for advanced HGSC once workup complete; later coordinate appropriate maintenance based on BRCA/HRD.
- Coordinate breast MDT to finalize endocrine ± radiation sequencing around ovarian chemotherapy, ensuring margins/nodes confirmed on synoptic report.

Change Triggers:
- If imaging/pathology reveal unresected bulky disease or higher FIGO stage, escalate systemic intensity and consider multidisciplinary review of local options.
- If germline/somatic BRCA or HRD positive, prioritize PARP-inclusive maintenance approach once ovarian first-line chemotherapy completed.
- If chest CT shows progressive lung nodules or metastatic pattern, re-stage as systemic disease and adjust ovarian regimen and goals.
- If baseline labs or performance status are poor, delay/intensify supportive care and de-escalate or modify systemic treatment plan.
- If breast pathology reveals unexpected high-risk features (e.g., positive margins/nodes), re-balance timing/intensity of breast radiation/systemic therapy versus ovarian treatment.

